CI

At a glance

ClinicalIndex Comparison Record
Phase 2Unknown· 99 enrolled
Drug / intervention
cryosurgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00723294
NCT00723294Phase 2Unknown
CompareCT.gov

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma

Alliance for Clinical Trials in Oncology·interventional·Posted Jul 28, 2008·Updated Aug 14, 2017

In Brief

A Phase 2 clinical trial evaluating cryosurgery and therapeutic conventional surgery for Breast Cancer. Targeting 99 participants across 16 sites.

Detailed Summary

This phase II trial is studying how well cryoablation therapy works in treating patients with invasive ductal breast cancer. Cryoablation kills tumor cells by freezing them. This may be an effective treatment for patients with invasive ductal breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2UnknownOverdue
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 28, 2008
Enrollment StartSep 1, 2008
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 17.9 years ago

Interventions

cryosurgeryprocedure

therapeutic conventional surgeryprocedure